Monday 25 May 2009

Dayhist-1




In the US, Dayhist-1 is a member of the drug class antihistamines and is used to treat Allergic Reactions, Hay Fever and Urticaria.

Ingredient matches for Dayhist-1



Clemastine

Clemastine fumarate (a derivative of Clemastine) is reported as an ingredient of Dayhist-1 in the following countries:


  • United States

International Drug Name Search

Saturday 23 May 2009

Chondron




Chondron may be available in the countries listed below.


Ingredient matches for Chondron



Chondroitin Polysulfate

Chondroitin Polysulfate sodium salt (a derivative of Chondroitin Polysulfate) is reported as an ingredient of Chondron in the following countries:


  • Japan

International Drug Name Search

Wednesday 13 May 2009

Zopep




Zopep may be available in the countries listed below.


Ingredient matches for Zopep



Omeprazole

Omeprazole is reported as an ingredient of Zopep in the following countries:


  • India

International Drug Name Search

Monday 11 May 2009

Diclofenac Na PCH




Diclofenac Na PCH may be available in the countries listed below.


Ingredient matches for Diclofenac Na PCH



Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Diclofenac Na PCH in the following countries:


  • Netherlands

International Drug Name Search

Nosca Mereprine




Nosca Mereprine may be available in the countries listed below.


Ingredient matches for Nosca Mereprine



Noscapine

Noscapine hydrochloride (a derivative of Noscapine) is reported as an ingredient of Nosca Mereprine in the following countries:


  • Belgium

  • Luxembourg

International Drug Name Search

Sunday 10 May 2009

Nitropress




In the US, Nitropress (nitroprusside systemic) is a member of the following drug classes: agents for hypertensive emergencies, vasodilators and is used to treat Heart Failure and Hypertensive Emergency.

US matches:

  • Nitropress

Ingredient matches for Nitropress



Nitroprusside

Sodium Nitroprusside is reported as an ingredient of Nitropress in the following countries:


  • Peru

  • United States

International Drug Name Search

Tuesday 5 May 2009

Edilox-OZ




Edilox-OZ may be available in the countries listed below.


Ingredient matches for Edilox-OZ



Ofloxacin

Ofloxacin is reported as an ingredient of Edilox-OZ in the following countries:


  • India

Ornidazole

Ornidazole is reported as an ingredient of Edilox-OZ in the following countries:


  • India

International Drug Name Search

Dilcontin Continus




Dilcontin Continus may be available in the countries listed below.


Ingredient matches for Dilcontin Continus



Diltiazem

Diltiazem hydrochloride (a derivative of Diltiazem) is reported as an ingredient of Dilcontin Continus in the following countries:


  • Bangladesh

International Drug Name Search

Monday 4 May 2009

Inibina




Inibina may be available in the countries listed below.


Ingredient matches for Inibina



Isoxsuprine

Isoxsuprine hydrochloride (a derivative of Isoxsuprine) is reported as an ingredient of Inibina in the following countries:


  • Brazil

International Drug Name Search

Sunday 3 May 2009

Casodex


Casodex is a brand name of bicalutamide, approved by the FDA in the following formulation(s):


CASODEX (bicalutamide - tablet; oral)



  • Manufacturer: ASTRAZENECA

    Approval date: October 4, 1995

    Strength(s): 50MG [RLD][AB]

Has a generic version of Casodex been approved?


A generic version of Casodex has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Casodex and have been approved by the FDA:


bicalutamide tablet; oral



  • Manufacturer: ACCORD HLTHCARE INC

    Approval date: July 6, 2009

    Strength(s): 50MG [AB]


  • Manufacturer: ACTAVIS TOTOWA

    Approval date: August 28, 2009

    Strength(s): 50MG [AB]


  • Manufacturer: FRESENIUS KABI ONCOL

    Approval date: May 13, 2010

    Strength(s): 50MG [AB]


  • Manufacturer: KUDCO IRELAND

    Approval date: July 6, 2009

    Strength(s): 50MG [AB]


  • Manufacturer: MYLAN

    Approval date: July 6, 2009

    Strength(s): 50MG [AB]


  • Manufacturer: ROXANE

    Approval date: March 24, 2011

    Strength(s): 50MG [AB]


  • Manufacturer: SANDOZ

    Approval date: July 6, 2009

    Strength(s): 50MG [AB]


  • Manufacturer: SUN PHARMA GLOBAL

    Approval date: July 6, 2009

    Strength(s): 50MG [AB]


  • Manufacturer: SYNTHON PHARMS

    Approval date: July 6, 2009

    Strength(s): 50MG [AB]


  • Manufacturer: TEVA

    Approval date: July 6, 2009

    Strength(s): 50MG [AB]


  • Manufacturer: ZYDUS PHARMS USA INC

    Approval date: July 6, 2009

    Strength(s): 50MG [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Casodex. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Casodex.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • December 19, 2011 - ADDITIONAL INFO FOR PEDIATRIC USE FOR CASODEX (STUDIED IN COMBINATION WITH ARIMIDEX) IN THE PEDIATRIC POPULATION, SPECIFICALLY BOYS WITH FAMILIAL MALE-LIMITED PRECOCIOUS PUBERTY (TESTOXICOSIS)

    • June 19, 2012 - PEDIATRIC EXCLUSIVITY

See also...

  • Casodex Consumer Information (Drugs.com)
  • Casodex Consumer Information (Wolters Kluwer)
  • Casodex Consumer Information (Cerner Multum)
  • Casodex Advanced Consumer Information (Micromedex)
  • Casodex AHFS DI Monographs (ASHP)
  • Bicalutamide Consumer Information (Wolters Kluwer)
  • Bicalutamide Consumer Information (Cerner Multum)
  • Bicalutamide Advanced Consumer Information (Micromedex)
  • Bicalutamide AHFS DI Monographs (ASHP)

Friday 1 May 2009

Niglumine




Niglumine may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Niglumine



Flunixin

Flunixin meglumine (a derivative of Flunixin) is reported as an ingredient of Niglumine in the following countries:


  • Italy

  • Portugal

International Drug Name Search